Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

KM Biologics reports phase I data on tetravalent dengue vaccine KD-382

March 25, 2021

AstraZeneca reports primary analysis of U.S. phase III trial of AZD-1222

March 25, 2021

CVnCoV protects against SARS-CoV-2 B.1.351 variant in preclinical challenge study

March 24, 2021

Clover initiates phase II/III study of adjuvanted S-Trimer COVID-19 vaccine candidate

March 24, 2021

Phase II trial underway in Mali for CIS-43LS to prevent P. falciparum infection

March 24, 2021

Remdesivir data in pediatric patients with COVID-19

March 24, 2021

Daiichi Sankyo's mRNA vaccine for COVID-19 enters phase I/II trial in Japan

March 23, 2021

Japanese approval of Arikayce for NTM lung disease caused by MAC

March 23, 2021

Regeneron reports topline phase III data on REGEN-COV in nonhospitalized COVID-19 patients

March 23, 2021

CanSino reports China NMPA clearance of clinical trial application for inhaled COVID-19 vaccine

March 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...